Table 1 Baseline characteristics and 14 day mortality of patients enrolled in the CRASH trial with mortality data available (n = 9978)
| Â | Corticosteroid (n = 4991) | Placebo (n = 4987) |
|---|---|---|
Age (median, interquartile range) | 33, 23-47 | 32, 23-47 |
Gender | ||
   Male | 4060 (81.3%) | 4016 (80.5%) |
Glasgow Coma Scale | ||
   Severe (3-8) | 1966 (39.4%) | 1966 (39.4%) |
   Moderate (9-12) | 1554 (31.1%) | 1479 (29.7%) |
   Mild (13-14) | 1471 (29.5%) | 1542 (30.9%) |
Pupillary reactivity | ||
   Both reactive to light | 4272 (85.6%) | 4016 (80.5%) |
14 day mortality | Â | Â |
   Dead | 1053 (21.1%) | 895 (17.9%) |